Current status and future perspectives in dysregulated miR-492

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• MicroRNAs (miRNAs) are small, non-coding RNA molecules regulating gene expression.
• miR-492, a specific miRNA, is implicated in various cellular processes and cancer development.
• Its dysregulation is observed across diverse cancer types, suggesting a significant role in oncogenesis.

Purpose of the Study:

• To systematically review and summarize current research on miR-492.
• To elucidate the role of miR-492 in cancer biology, including its targets and regulatory pathways.
• To highlight the clinical significance of miR-492, particularly its association with patient survival.

Main Methods:

• Literature review of studies investigating miR-492.
• Analysis of miR-492's genomic location and biogenesis.
• Examination of miR-492's molecular targets and signaling pathway involvement.
• Correlation analysis of miR-492 expression levels with patient survival data.

Main Results:

• miR-492 is encoded within the KRT19 pseudogene and can be processed from KRT19 transcripts.
• It targets at least 11 protein-coding genes involved in cell growth, proliferation, and metastasis (EMT).
• miR-492 expression is linked to PI3K/AKT, WNT/β-catenin, and MAPK signaling pathways.
• High miR-492 expression is associated with reduced survival in gastric, ovarian, oropharyngeal, colorectal, and hepatocellular cancers.

Conclusions:

• miR-492 plays a crucial role in cancer progression and is a potential prognostic biomarker.
• Understanding miR-492's regulatory mechanisms and targets can offer insights for therapeutic strategies.
• Further research is warranted to fully explore miR-492's clinical utility in oncology.